SLIT LAMP SL-D4 (Type: LED)
Topcon Corporation · Decision date Sep 18, 2026
What did the FDA decide?
Topcon Corporation received a substantially equivalent (SESE) decision for the SLIT LAMP SL-D4 (Type: LED) under 510(k) K262637, dated September 18, 2026, with the application received July 29, 2026. The device is a Class II AC-powered slitlamp biomicroscope under 21 CFR 886.1850, product code HJO, in the Ophthalmic specialty. This is a clearance, not a PMA approval.
The submission identifies the Slit Lamp SL-D701 (K133667), also held by Topcon, as the predicate. The summary states the intended use, operating principle and technological characteristics are similar or equivalent, and lists non-clinical testing against ANSI AAMI ES60601-1, IEC 60601-1-2, ISO 15004-1, ANSI Z80.36 and ANSI Z80.37. The record does not include clinical performance data, and the summary's 510(k) number field for the subject device reads "Not yet known."
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262637
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Topcon Corporation
- Product code
- HJO
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Biomicroscope, Slit-Lamp, Ac-Powered.
- Applicant
- Topcon Corporation
- Product code
- HJO
- FDA device class
- 2
FDA decision timeline
K262637 received
Application receipt date recorded by FDA.
K262637 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Topcon Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tokyo
Sources and methodology
- Original FDA record: K262637
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records